Transparent Film Dressing Versus Microporous Paper Tape for Temperature Probe Fixation in Preterm Neonates: A Randomized Controlled Trial.

Indian PediatrJun 22, 2026 (epub)
Clinical ResearchPediatricsOpen access

Aditya Hemendra Bhatt, Dipen Vasudev Patel, Mayur Kiran Shinde et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial compared transparent film dressing with microporous paper tape for securing temperature probes in preterm neonates receiving radiant warmer care. Among 128 neonates, any probe-site skin damage occurred in 64.1% with microporous tape and 59.4% with film dressing (P = 0.585), with no significant difference in the overall outcome. Skin dryness was more frequent with microporous tape (54.7% vs. 31.3%, P = 0.007); erythema and skin breakdown were comparable between groups.

Key findings

  • Any skin damage occurred in 41/64 (64.1%) with microporous tape versus 38/64 (59.4%) with film dressing (P = 0.585).
  • Skin dryness was more frequent with microporous tape than film dressing (54.7% vs. 31.3%, P = 0.007).
  • Erythema and skin breakdown did not differ significantly between groups.

Why it matters

Probe fixation can affect neonatal skin integrity, and this trial found frequent skin damage with both methods. Although the overall incidence was similar, the higher rate of dryness with microporous tape suggests that the type of skin change may vary by fixation material. These findings help frame skin monitoring as relevant when securing temperature probes in preterm neonates.

Source

Published in Indian Pediatr. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.